Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0. This change does not affect core study details or patient-facing information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

- Check61 days agoChange DetectedThe change is limited to a revision number update from v3.4.0 to v3.4.1; no study content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page adds a visible glossary and updates QC-related labels (e.g., Last Update Submitted that Met QC Criteria) with Revision: v3.4.0, while older QC wording and the No FEAR Act data phrasing were removed.SummaryDifference0.2%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.